Biotechnology & Pharmaceuticals

Biotechnology and pharmaceutical companies develop innovative and life-changing treatments, and securing and enforcing intellectual property rights is crucial for ensuring these novel therapies reach patients in need. MBHB’s team of attorneys, patent agents and technical advisors draws on IP law expertise and deep scientific backgrounds to guide life sciences companies on all aspects of their IP strategies – from patent procurement and post-grant challenges to litigation.

Leadership

Expert IP counsel on cutting-edge subject matter

Our Biotechnology and Pharmaceuticals Practice team is made up of experienced patent attorneys, patent agents and technical advisors with advanced degrees and industry experience.  All our life sciences team members hold advanced degrees in areas such as molecular biology, genetics, human nutrition, plant sciences and organic chemistry.  This background enables us to apply our deep knowledge and hands-on research and lab experience to science-intensive analyses of life sciences innovations.  

With this combination of scientific expertise and legal experience, we are able to understand the intricacies of life sciences innovations and guide clients on effective strategies to secure and enforce their IP rights. We work with our clients on cutting-edge subject matter – from antibiotics and vaccines to therapeutic small molecules and diagnostic methods and assays. 

Comprehensive IP strategy for life sciences

Our life sciences practice represents a wide range of organizations – from start-ups and university spin-out companies to major biotechnology and pharmaceutical companies – across the IP lifecycle. We help clients build and manage patent portfolios, develop licensing strategies and navigate complex litigation We also guide clients on licensing and technology transfer strategies, offer opinions on patent validity and infringement, support clients in oppositions and post-grant proceedings, and more. 

Supporting life sciences commercial success

Our legal team’s experience includes strategic development and protection of IP for Fortune500 multinational corporations, emerging biopharma companies, universities, and small and micro-entities, including individual inventors. We also have significant experience working with counsel in numerous countries and regions to help our clients secure global protection of their IP. Across all aspects of our support for biotechnology and pharmaceutical clients, we maintain a consistent focus on our client’s business goals, understanding the integral role IP rights play in eventual commercial success. 

Subscribe

Get all the latest updates on the biotechnology and pharmaceutical industry
Search
Menu
Menu